Eagle Meds Services
Rinvoq (Upadacitinib)
Available to sourceHuman Prescription DrugOncology & Specialty

Rinvoq (Upadacitinib)

45 mg/1 · Extended-Release Tablet
By AbbVie Inc.
NDC
0074-1043
Route
Oral
Therapeutic class
Janus Kinase Inhibitor , Janus Kinase Inhibitors [MoA]
Marketing category
NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Rinvoq (Upadacitinib)
NDC 0074-1043
(980) 480-3410 requests@eaglemedsservices.com

Related in Oncology & Specialty

See all →
Verzenio (abemaciclib)

Verzenio (abemaciclib)

50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

150 mg/1 · Tablet
Eli Lilly and Company
Available to source